Effects of Cilostazol on Vascular Endothelial Growth Factor , Inflammatory and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cilostazol (Primary)
- Indications Embolism and thrombosis; Peripheral vascular disorders
- Focus Pharmacodynamics
- 12 May 2015 Biomarkers information updated
- 07 Apr 2008 Status changed from recruiting to completed, according to ClinicalTrials.gov.
- 07 Mar 2007 New trial record.